Intensity Therapeutics
Mario Sznol is currently an advisor at Intensity Therapeutics. Mario has over 25 years of experience in drug development.
Mario Sznol began their career in drug development at the National Cancer Institute (NCI) in July 1987. Mario served as the head of the Biologics Evaluation Section and was responsible for the Investigational Drug Branch of CTEP. Mario left NCI in September 1999 to join Vion Pharmaceuticals as Vice President.
At Vion, Mario was responsible for drug development. Mario left Vion in October 2004 to join Intensity Therapeutics as an advisor.
Mario Sznol has a Doctor of Medicine (MD) from Baylor College of Medicine and a Bachelor's degree in Biochemistry from Rice University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Intensity Therapeutics
1 followers
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.